Status | Study |
NOT_YET_RECRUITING |
Study Name: Immunology of Ebola Vaccine Condition: Ebola Virus Disease Date: 2023-10-20 Interventions: The study vaccine is an FDA-approved recombinant vesicular stomatitis virus (rVSV) expressing the envelope glycoprotein of Ebola virus Zaire (rVSV?G-Z |
Not yet recruiting |
Study Name: Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine Condition: Ebola Virus Disease Date: 2017-05-18 Interventions: Biological: rVSVΔG-ZEBOV-GP Ring vaccination with vaccination of contacts and contacts of contacts |
Enrolling by invitation |
Study Name: Persistence of the Immune Response After Ebola Vaccine Immunisation Condition: Ebola Virus Disease Date: 2017-05-02 |
Recruiting |
Study Name: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response Condition: Ebola Virus Disease Date: 2017-03-30 |
Recruiting |
Study Name: Partnership for Research on Ebola VACcinations Condition: Ebola Virus Disease Date: 2016-08-16 Interventions: Biological: Ad26.ZEBOV 0.5 mL |
Completed |
Study Name: Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults Condition: Ebola Virus Disease Date: 2016-03-09 Interventions: Biological: Ebola Vaccine - low dose |
Completed |
Study Name: Efficacy of Favipiravir Against Severe Ebola Virus Disease Condition: Ebola Virus Disease Date: 2016-01-19 Interventions: Other: WHO-recommended therapies |
Completed |
Study Name: Evaluation of the FilmArray BioThreat-E Test Condition: Ebola Virus Disease Date: 2016-01-06 |
Completed |
Study Name: A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine Condition: Ebola Disease Date: 2015-10-11 Interventions: Biological: Ebola Vaccine Biological: Plac |
Completed |
Study Name: A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization Condition: Ebola Virus Disease Date: 2015-08-21 Interventions: Biological: 4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV) |